No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 0.4x · 10Y median 0.3x · 67th percentile · as of Oct 6, 2026
Annual revenue · last 3 fiscal years + TTM
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T17:57:45.972Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T17:57:45.972Z. Latest historical point 2026-08-13. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T17:57:45.972Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T17:57:45.972Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T17:57:45.972Z. Latest historical point 2026-03-25.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T17:57:45.972Z. Latest historical point 2026-08-13. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T17:57:45.972Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T17:57:45.972Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Park Dental Partners, Inc. Common Stock (PARK) stock was $20.45 as of Oct 6, 2026, 1:54 PM EDT, down 3.03% from the previous close.
Park Dental Partners, Inc. operates as a dental support organization, providing a wide array of non-clinical and operational assistance to dental professionals throughout Minnesota and Wisconsin.
Medical - Care Facilities · Roseville, MN
Next Earnings Date
Nov 11, 2026
36 days away
EPS Estimate
0.27
Revenue Est.
$64.61M
Last Quarter Results
EPS
$0.66
vs Estimate
$0.33
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1PARK | $92.33M | $20.45 | -3.03% | N/A | N/A | N/A | N/A |
| 2EQ | $90.73M | $1.44 | -1.03% | -3.34% | -26.99% | N/A | vs PARK |
| 3BMEA | $90.37M | $1.25 | -3.85% | -39.39% | -36.56% | N/A | vs PARK |
| 4RLYB | $90.32M | $17.02 | +0.71% | +271.55% | -35.80% | N/A | vs PARK |
| 5ECOR | $89.53M | $9.93 | -1.97% | +101.52% | -8.10% | N/A | vs PARK |
| 6PMVP | $89.33M | $1.68 | -5.90% | +23.49% | -43.17% | N/A | vs PARK |
forward FY estimate
12.32
$66.21M
vs Estimate
$64.35M
Consensus Rating
Based on 2 analysts
Average Price Target
$28.50
+39.4% upside
Low
$27.00
Current
$20.45
High
$30.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.30 | $0.30 | $0.30 | 1 |
| Quarter ending Dec 2026 | $0.27 | $0.27 | $0.27 | 1 |
| Quarter ending Mar 2027 | $0.29 | $0.29 | $0.29 | 1 |
| Quarter ending Jun 2027 | $0.45 | $0.46 | $0.46 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $1.60 | $1.66 | $1.72 | 1 |
| FY 2027 | $1.52 | $1.58 | $1.64 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $64.50M | $64.61M | $64.72M | 1 |
| Quarter ending Dec 2026 | $64.56M | $64.68M | $64.79M | 1 |
| Quarter ending Mar 2027 | $72.28M | $72.41M | $72.53M | 1 |
| Quarter ending Jun 2027 | $76.18M | $76.31M | $76.44M | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Dec 31, 2026, matching Key Metrics.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $250.77M | $258.14M | $265.51M | 1 |
| FY 2027 | $290.15M | $298.68M | $307.20M | 1 |
